Landscapes / Targets
B7-H3
27 drugs act on B7-H3, in 100 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs27
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Small Cell Lung Cancer Extensive Stage, Advanced/Metastatic Solid Tumors and 8 more | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
Phase 3 | Jan 2027Phase 1/2 trial completes | |||
| How it works | An antibody | ||||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Solid Tumors and 10 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 3 | 30 Apr 2027Phase 1/2 trial completes | |||
| How it works | An antibody | ||||
| Next date | 30 Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Carcinoma, Non-Small-Cell Lung, Small Cell Lung Cancer and 13 more | ||||
| Open drug page | |||||
— |
CSPC · Public 1093.HK |
Phase 3 | 30 Oct 2027Phase 1/2 trial completes | ||
| Next date | 30 Oct 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Advanced/Metastatic Solid Tumors and 4 more | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
Phase 3 | 5 Nov 2027Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | 5 Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Neoplasms, Lung, Gastrointestinal Neoplasms and 1 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Nov 2027Phase 3 trial completes | |||
| Next date | 30 Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer, Neoplasms and 19 more | ||||
| Open drug page | |||||
B7-H3-targeted antibody-drug conjugate |
Phase 3 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor, Lung Squamous Cell Carcinoma | ||||
| Open drug page | |||||
— |
BioNTech · Public BNTX |
Phase 3 | Dec 2027Phase 1/2 trial completes | ||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Advanced Lung Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed Neuroblastoma, Refractory Neuroblastoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer | ||||
| Open drug page | |||||
— |
Merck & Co. · Public MRK |
Phase 2 | 12 Jun 2027Phase 1/2 trial completes | ||
| Next date | 12 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Lung Neoplasm, Esophageal Squamous Cell Carcinoma and 2 more | ||||
| Open drug page | |||||
— |
3SBio · Public 1530.HK |
Phase 2 | Nov 2027Phase 2 trial completes | ||
| Next date | Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Malignant Tumors, NMIBC and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer and 9 more | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Aug 2028Phase 2 trial completes | |||
| Next date | 1 Aug 2028 · Phase 2 trial completes | ||||
| Also tested for | Advanced Malignant Tumors, Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | Oct 2028Phase 2 trial completes | |||
| Next date | Oct 2028 · Phase 2 trial completes | ||||
| Also tested for | Diffuse Intrinsic Pontine Glioma, DIPG and 10 more | ||||
| Open drug page | |||||
— |
Phase 2 | 13 Dec 2028Phase 2 trial completes | |||
| Next date | 13 Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumor, Malignant Pleural Effusion and 10 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2026Phase 1 trial completes | |||
| Next date | 30 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Lung Cancer (NSCLC), Prostate Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Locally Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jul 2027Phase 1 trial completes | |||
| Next date | 30 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Esophageal Squamous Cell Carcinoma, High Grade Serous Ovarian Cancer and 6 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer) and 12 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 26 of 27 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026